{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:37:28Z","timestamp":1774377448201,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":155,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1593\/tlo.13613","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T09:54:49Z","timestamp":1395741289000},"page":"749-IN36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Three-dimensional Nuclear Telomere Organization in Multiple Myeloma"],"prefix":"10.1016","volume":"6","author":[{"given":"Ludger","family":"Klewes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea","family":"Vallente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Dupas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"Gr\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Guffei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirawadee","family":"Sathitruangsak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius A.","family":"Awe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Kuzyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Lichtensztejn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pille","family":"Tammur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiiu","family":"Ilus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Punab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morel","family":"Rubinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adebayo","family":"Olujohungbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1593\/tlo.13613_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.mayocp.2012.06.014","article-title":"Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition","volume":"87","author":"Therneau","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1593\/tlo.13613_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1468-0734.2002.00076.x","article-title":"Monoclonal gammopathies of undetermined significance","volume":"6","author":"Kyle","year":"2002","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1593\/tlo.13613_bib3","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"key":"10.1593\/tlo.13613_bib4","series-title":"Postgraduate Haematology","first-page":"681","article-title":"Myeloma","author":"Terpos","year":"2007"},{"key":"10.1593\/tlo.13613_bib5","first-page":"43","article-title":"Cancer statistics","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1593\/tlo.13613_bib6","unstructured":"http:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html#incidence-mortality\">http:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html#incidence-mortality"},{"key":"10.1593\/tlo.13613_bib7","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/480S34a","article-title":"Overview: multiple lines of attack","volume":"14","author":"Graham-Rowe","year":"2011","journal-title":"Nature"},{"key":"10.1593\/tlo.13613_bib8","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/leu.2009.134","article-title":"Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis","volume":"23","author":"Landgren","year":"2009","journal-title":"Leukemia"},{"key":"10.1593\/tlo.13613_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1593\/tlo.13613_bib10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"10.1593\/tlo.13613_bib11","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2010.1713","article-title":"Multiple myeloma precursor disease","volume":"304","author":"Landgren","year":"2010","journal-title":"JAMA"},{"key":"10.1593\/tlo.13613_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.seminhematol.2010.11.008","article-title":"Multiple myeloma precursor disease: current clinical dilemma and future opportunities","volume":"48","author":"Landgren","year":"2011","journal-title":"Semin Hematol"},{"key":"10.1593\/tlo.13613_bib13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2141.2007.06873.x","article-title":"Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression","volume":"139","author":"Kyle","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1593\/tlo.13613_bib14","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood-2010-05-284422","article-title":"Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival","volume":"117","author":"Steinbrunn","year":"2011","journal-title":"Blood"},{"key":"10.1593\/tlo.13613_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/152581602753448522","article-title":"A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies","volume":"11","author":"Rajkumar","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1593\/tlo.13613_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hon.2065","article-title":"V. Molecular classification and risk stratification of myeloma","volume":"31","author":"Bergsagel","year":"2013","journal-title":"Hematol Oncol"},{"key":"10.1593\/tlo.13613_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/B978-0-12-387688-1.00004-1","article-title":"Nuclear remodeling as a mechanism for genomic instability in cancer","volume":"112","author":"Gadji","year":"2011","journal-title":"Adv Cancer Res"},{"key":"10.1593\/tlo.13613_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.beha.2007.08.004","article-title":"Genetic events in the pathogenesis of multiple myeloma","volume":"20","author":"Chng","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1593\/tlo.13613_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"10.1593\/tlo.13613_bib20","unstructured":"http:\/\/www.themmrf.org\/research-programs\/commpass-study\/#sthash.apOWszeO.dpuf\">http:\/\/www.themmrf.org\/research-programs\/commpass-study\/#sthash.apOWszeO.dpuf"},{"key":"10.1593\/tlo.13613_bib21","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1593\/tlo.13613_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1593\/tlo.13613_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","article-title":"The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system","volume":"42","author":"Durie","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1593\/tlo.13613_bib24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/leu.2009.61","article-title":"Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant","volume":"23","author":"Hari","year":"2009","journal-title":"Leukemia"},{"key":"10.1593\/tlo.13613_bib25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4065\/mcp.2010.0304","article-title":"Diagnosis and management of Waldenstr\u00f6m macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines","volume":"85","author":"Ansell","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1593\/tlo.13613_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3816\/CLML.2011.n.012","article-title":"Factors predicting transformation of asymptomatic IgM monoclonal gammopathy","volume":"11","author":"Greco","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1593\/tlo.13613_bib27","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood.V84.8.2597.2597","article-title":"Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells","volume":"84","author":"Pellat-Deceunynck","year":"1994","journal-title":"Blood"},{"key":"10.1593\/tlo.13613_bib28","first-page":"1521","article-title":"CD28, a marker associated with tumoral expansion in multiple myeloma","volume":"4","author":"Robillard","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1593\/tlo.13613_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.2002.03258.x","article-title":"Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma","volume":"116","author":"Dahl","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1593\/tlo.13613_bib30","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/cncr.21746","article-title":"Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic\/Th1 T cells demonstrating a squed TCR-V\u03b2 repertoire","volume":"106","author":"P\u00e9rez-Andres","year":"2006","journal-title":"Cancer"},{"key":"10.1593\/tlo.13613_bib31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.leu.2403647","article-title":"Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment","volume":"19","author":"P\u00e9rez-Andr\u00e9s","year":"2005","journal-title":"Leukemia"},{"key":"10.1593\/tlo.13613_bib32","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ejca.2005.11.039","article-title":"Conventional diagnostics in multiple myeloma","volume":"42","author":"San Miguel","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1593\/tlo.13613_bib33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3324\/haematol.11080","article-title":"Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders","volume":"93","author":"Rawstron","year":"2008","journal-title":"Haematologica"},{"issue":"3\u20134","key":"10.1593\/tlo.13613_bib34","first-page":"392","article-title":"Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathies","volume":"18","author":"P\u00e9rez-Andr\u00e9s","year":"2004","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1593\/tlo.13613_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1741-7007-2-12","article-title":"The three-dimensional organization of telomeres in the nucleus of mammalian cells","volume":"2","author":"Chuang","year":"2004","journal-title":"BMC Biol"},{"key":"10.1593\/tlo.13613_bib36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4161\/cc.4.10.2082","article-title":"Oncogenic remodeling of the three-dimensional organization of the interphase nucleus: c-Myc induces telomeric aggregates whose formation precedes chromosomal rearrangements","volume":"4","author":"Mai","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1593\/tlo.13613_bib37","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/jcb.20760","article-title":"The significance of telomeric aggregates in the interphase nuclei of tumor cells","volume":"97","author":"Mai","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1593\/tlo.13613_bib38","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.0407512102","article-title":"c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus","volume":"102","author":"Louis","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/tlo.13613_bib39","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/jcb.22501","article-title":"Initiation of telomere-mediated chromosomal rearrangements in cancer","volume":"109","author":"Mai","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1593\/tlo.13613_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-pathol-020712-164030","article-title":"The role of telomere biology in cancer","volume":"24","author":"Xu","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"10.1593\/tlo.13613_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cyto.a.20159","article-title":"Characterizing the three-dimensional organization of telomeres","volume":"67","author":"Vermolen","year":"2005","journal-title":"Cytometry A"},{"key":"10.1593\/tlo.13613_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1593\/neo.91752","article-title":"Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients","volume":"12","author":"Gadji","year":"2010","journal-title":"Neoplasia"},{"key":"10.1593\/tlo.13613_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/gcc.22046","article-title":"Nuclear remodeling of telomeres in chronic myeloid leukemia","volume":"52","author":"Samassekou","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1593\/tlo.13613_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12185-010-0750-2","article-title":"Telomeres and prognosis in patients with chronic lymphocytic leukaemia","volume":"93","author":"Sellmann","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1593\/tlo.13613_bib45","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1182\/blood-2010-02-272104","article-title":"Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis","volume":"116","author":"Lin","year":"2010","journal-title":"Blood"},{"key":"10.1593\/tlo.13613_bib46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng.2584","article-title":"POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia","volume":"45","author":"Ramsay","year":"2013","journal-title":"Nat Genet"},{"key":"10.1593\/tlo.13613_bib47","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.leukres.2011.09.004","article-title":"Jumping translocations of 3q21 in an acute monocytic leukemia (M5) patient reveal mechanisms of multistage telomere shortening in pathogenesis of AML","volume":"36","author":"Zou","year":"2012","journal-title":"Leuk Res"},{"key":"10.1593\/tlo.13613_bib48","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1158\/1078-0432.CCR-12-0087","article-title":"Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups","volume":"18","author":"Gadji","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1593\/tlo.13613_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.aanat.2010.07.006","article-title":"3D structural and functional characterization of the transition from Hodgkin to Reed-Sternberg cells","volume":"192","author":"Knecht","year":"2010","journal-title":"Ann Anat"},{"key":"10.1593\/tlo.13613_bib50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-59745-406-3_15","article-title":"Multicolor 3D fluorescence in situ hybridization for imaging interphase chromosomes","volume":"463","author":"Cremer","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1593\/tlo.13613_bib51","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3324\/haematol.2010.030171","article-title":"Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles","volume":"95","author":"Guffei","year":"2010","journal-title":"Haematologica"},{"key":"10.1593\/tlo.13613_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2818.2001.00949.x","article-title":"Generalized approach for accelerated maximum likelihood based image restoration applied to three-dimensional fluorescence microscopy","volume":"204","author":"Schaefer","year":"2001","journal-title":"J Microsc"},{"key":"10.1593\/tlo.13613_bib53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1593\/tlo.12142","article-title":"Three-dimensional telomere signatures of Hodgkin- and Reed-Sternberg cells at diagnosis identify patients with poor response to conventional chemotherapy","volume":"5","author":"Knecht","year":"2012","journal-title":"Transl Oncol"},{"key":"10.1593\/tlo.13613_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2121-11-99","article-title":"3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including \u201ct-stumps\u201d","volume":"11","author":"Knecht","year":"2010","journal-title":"BMC Cell Biol"},{"key":"10.1593\/tlo.13613_bib55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.molcel.2007.10.005","article-title":"Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres","volume":"28","author":"Xu","year":"2007","journal-title":"Mol Cell"},{"key":"10.1593\/tlo.13613_bib56","article-title":"Three-dimensional telomere dynamics in follicular thyroid cancer","author":"Wark","year":"2013","journal-title":"Thyroid"},{"key":"10.1593\/tlo.13613_bib57","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/gcc.22067","article-title":"Three-dimensional nuclear telomere architecture changes during endometrial carcinoma development","volume":"52","author":"Danescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1593\/tlo.13613_bib58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1593\/tlo.12361","article-title":"Three-dimensional telomeric analysis of isolated circulating tumor cells (CTCs) defines CTC subpopulations","volume":"6","author":"Adebayo Awe","year":"2013","journal-title":"Transl Oncol"},{"key":"10.1593\/tlo.13613_bib59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1593\/neo.12446","article-title":"Selected telomere length changes and aberrant three-dimensional nuclear telomere organization during fast-onset mouse plasmacytomas","volume":"14","author":"Kuzyk","year":"2013","journal-title":"Neoplasia"},{"key":"10.1593\/tlo.13613_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/LGT.0b013e31803c4df0","article-title":"Premalignant cervical lesions are characterized by dihydrofolate reductase gene amplification and c-Myc overexpression: possible biomarkers","volume":"11","author":"Guijon","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"10.1593\/tlo.13613_bib61","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1038\/sj.onc.1208467","article-title":"Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein","volume":"24","author":"Fest","year":"2005","journal-title":"Oncogene"},{"key":"10.1593\/tlo.13613_bib62","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1038\/sj.onc.1205274","article-title":"c-MYC overexpression in Ba\/F3 cells simultaneously elicits genomic instability and apoptosis","volume":"21","author":"Fest","year":"2002","journal-title":"Oncogene"},{"key":"10.1593\/tlo.13613_bib63","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2008.314","article-title":"The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells","volume":"23","author":"Knecht","year":"2009","journal-title":"Leukemia"},{"key":"10.1593\/tlo.13613_bib64","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2141.2005.05647.x","article-title":"Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival","volume":"130","author":"Lovell","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1593\/tlo.13613_bib65","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2141.1996.d01-1811.x","article-title":"A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1","volume":"94","author":"Wijdenes","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1593\/tlo.13613_bib66","series-title":"The Biomedical Scientist","first-page":"952","article-title":"CD138 expression on circulating myeloma cells: disease activity correlation","author":"Merryweather","year":"2009"},{"key":"10.1593\/tlo.13613_bib67","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrc1430","article-title":"Nuclear structure in cancer cells","volume":"4","author":"Zink","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/tlo.13613_bib68","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2011.09022.x","article-title":"Telomere dysfunction and its role in haematological cancer","volume":"156","author":"Jones","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1593\/tlo.13613_bib69","first-page":"91","article-title":"The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease","volume":"111","author":"Gancarc\u00edkov\u00e1","year":"2010","journal-title":"Prague Med Rep"},{"key":"10.1593\/tlo.13613_bib70","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/gcc.20737","article-title":"Telomere shortening and chromosomal instability in myelodysplastic syndromes","volume":"49","author":"Lange","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1593\/tlo.13613_bib71","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3109\/10428194.2011.568648","article-title":"Telomere length in myelodysplastic syndromes","volume":"52","author":"Rollison","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1593\/tlo.13613_bib72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood-2009-12-257618","article-title":"Telomere dysfunction-induced foci arise with the onset of telomeric deletions and complex chromosomal aberrations in resistant chronic lymphocytic leukemia cells","volume":"116","author":"Brugat","year":"2010","journal-title":"Blood"},{"key":"10.1593\/tlo.13613_bib73","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ajh.23466","article-title":"Short telomere length is associated with NOTCH1\/SF3B1\/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients","volume":"88","author":"Mansouri","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1593\/tlo.13613_bib74","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.leukres.2010.11.026","article-title":"Concomitant telomere shortening, acquisition of multiple chromosomal aberrations and in vitro resistance to apoptosis in a single case of progressive CLL","volume":"35","author":"Brugat","year":"2011","journal-title":"Leuk Res"},{"key":"10.1593\/tlo.13613_bib75","article-title":"The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas","author":"Leufke","year":"2013","journal-title":"Oncogene"},{"key":"10.1593\/tlo.13613_bib76","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1101\/gad.1214504","article-title":"Functional links between telomeres and proteins of the DNA-damage response","volume":"18","author":"d'Adda di Fagagna","year":"2004","journal-title":"Genes Dev"},{"key":"10.1593\/tlo.13613_bib77","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence","volume":"426","author":"d'Adda di Fagagna","year":"2003","journal-title":"Nature"},{"key":"10.1593\/tlo.13613_bib78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3892\/ol_00000060","article-title":"Abundance of a distinct cluster of telomere t-stumps in advanced breast cancer cell line","volume":"1","author":"Pai","year":"2010","journal-title":"Oncol Lett"},{"key":"10.1593\/tlo.13613_bib79","article-title":"Circulating clonotypic B-cells in multiple myeloma and monoclonal gammopathy of undetermined significance","author":"Thiago","year":"2013","journal-title":"Haematologica"},{"key":"10.1593\/tlo.13613_bib80","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V92.8.2844","article-title":"A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction","volume":"92","author":"Szczepek","year":"1998","journal-title":"Blood"},{"key":"10.1593\/tlo.13613_bib81","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V85.2.436.436","article-title":"The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements","volume":"85","author":"Bergsagel","year":"1995","journal-title":"Blood"},{"key":"10.1593\/tlo.13613_bib82","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/leu.2012.226","article-title":"Minor clone provides a reservoir for relapse in multiple myeloma","volume":"27","author":"Magrangeas","year":"2013","journal-title":"Leukemia"},{"key":"10.1593\/tlo.13613_bib83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cyto.a.21012","article-title":"Novel automated three-dimensional genome scanning based on the nuclear architecture of telomeres","volume":"79","author":"Klewes","year":"2011","journal-title":"Cytometry A"},{"key":"10.1593\/tlo.13613_bib84","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.bbmt.2012.05.009","article-title":"Minimal residual disease in myeloma: are we there yet?","volume":"18","author":"Hart","year":"2012","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523313800150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523313800150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:28:24Z","timestamp":1761834504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523313800150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1936523313800150"],"URL":"https:\/\/doi.org\/10.1593\/tlo.13613","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-dimensional Nuclear Telomere Organization in Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1593\/tlo.13613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Neoplasia Press Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}